Ronald D. Henriksen is Director at CYTORI THERAPEUTICS, INC. (CYTX). They have made 6 open-market trades across 1 company since 2006, most recently 2012-01-01.
CIK 0001202429
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $101K since 2006, against 1 sale. Across 5 scored buys the stock is down 1.4% at ninety days, and 1.7 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CYTX | 70,092 | $15K |
Shares reported on the most recent Form 4, priced at the 2012-01-04 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -23.7% | -1.4% | -1.4% |
| Alpha | -17.8% | -1.7% | -1.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYTX | BUY | 2011-08-12 | 2011-08-12 | $3.10 | $6K | -23.7% | -1.4% | -1.4% |
| CYTX | BUY | 2009-05-07 | 2009-05-11 | $2.28 | $50K | -23.7% | -1.4% | -1.4% |
| CYTX | BUY | 2008-11-17 | 2008-11-18 | $2.66 | $13K | -23.7% | -1.4% | -1.4% |
| CYTX | SELL | 2008-10-10 | 2008-10-14 | $3.12 | $12K | -23.7% | -1.4% | -1.4% |
| CYTX | BUY | 2008-10-09 | 2008-10-14 | $3.81 | $8K | -23.7% | -1.4% | -1.4% |
| CYTX | BUY | 2006-12-04 | 2006-12-06 | $4.73 | $24K | -23.7% | -1.4% | -1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.